Authors' Reply: SGLT2 Inhibitors vs GLP-1 Receptor Agonists Type 2 Diabetes, the Kidney Conundrum.
Saved in:
| Title: | Authors' Reply: SGLT2 Inhibitors vs GLP-1 Receptor Agonists Type 2 Diabetes, the Kidney Conundrum. |
|---|---|
| Authors: | Blum MF; Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin., Grams ME; Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York. |
| Source: | Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2026 Apr 24. Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1555-905X |
|---|---|
| DOI: | 10.2215/CJN.0000001074 |
